936361-36-3

Basic information

• Product Name: 3,8-Dibromoimidazo[1,2-a]pyrazine
• Synonyms: 3,8-Dibromoimidazo[1,2-a]pyrazine
• CAS NO: 936361-36-3
• Molecular Formula: C₆H₃Br₂N₃
• Molecular Weight: 276.91612
• Mol File: 936361-36-3.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3,8-Dibromoimidazo[1,2-a]pyrazine(CAS DataBase Reference)
• NIST Chemistry Reference: 3,8-Dibromoimidazo[1,2-a]pyrazine(936361-36-3)
• EPA Substance Registry System: 3,8-Dibromoimidazo[1,2-a]pyrazine(936361-36-3)

Safety Data

• Hazardous Substances Data: 936361-36-3(Hazardous Substances Data)

Upstream product

• 274-79-3 imidazo[1,2-a]pyrazine 
• 69214-33-1 8-chloroimidazo[1,2-α]pyrazine 

Downstream Products

• 787590-51-6 (3-bromo-imidazo[1,2-a]pyrazin-8-yl)-(4-methoxy-phenyl)-amine 
• 117718-92-0 8-amino-3-bromoimidazo<1,2-a>pyrazine 
• 887474-76-2 C₁₄H₁₄BrN₅ 
• 1011472-09-5 3-bromo-N-phenylimidazo[1,2-a]pyrazin-8-amine 
• 1231257-91-2 3-bromo-N-cyclohexylimidazo[1,2-a]pyrazin-8-amine 
• 887475-39-0 3-bromo-8-methylsulfanyl-imidazo[1,2-a]pyrazine 
• 1231257-89-8 3-bromo-8-((3-(trifluoromethyl)phenyl)amino)imidazo[1,2-a]pyrazine 

Relevant articles and documents

IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES

The present invention relates to novel imidazo[1,2-a]pyrazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.

COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Compounds of formula (I): wherein R1, R2, X1, and X2 are as defined herein, are useful for the treatment or prophylaxis of conditions such as Duchenne muscular dystrophy, Becker muscular dystrophy, and cachexia.